• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:COVID-19 相关自身免疫性脑炎大剂量类固醇和 IVIG 成功治疗一例:文献复习。

Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review.

机构信息

Department of Medical Education, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan, Taiwan.

Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

出版信息

Front Immunol. 2023 Sep 22;14:1240089. doi: 10.3389/fimmu.2023.1240089. eCollection 2023.

DOI:10.3389/fimmu.2023.1240089
PMID:37809102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10557068/
Abstract

Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.

摘要

自身免疫性脑炎是 COVID-19 的一种罕见但严重的并发症。COVID-19 相关自身免疫性脑炎的治疗包括使用类固醇、静脉注射免疫球蛋白 (IVIG)、血浆置换和单克隆抗体治疗。本研究介绍了一例重症 COVID-19 自身免疫性脑炎患者,在开始使用皮质类固醇和 IVIG 治疗后迅速康复。本研究回顾了 COVID-19 相关自身免疫性脑炎的病理生理机制、诊断和治疗的现有文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5696/10557068/7c194dec1127/fimmu-14-1240089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5696/10557068/a2cc2b0180bb/fimmu-14-1240089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5696/10557068/7c194dec1127/fimmu-14-1240089-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5696/10557068/a2cc2b0180bb/fimmu-14-1240089-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5696/10557068/7c194dec1127/fimmu-14-1240089-g002.jpg

相似文献

1
Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review.病例报告:COVID-19 相关自身免疫性脑炎大剂量类固醇和 IVIG 成功治疗一例:文献复习。
Front Immunol. 2023 Sep 22;14:1240089. doi: 10.3389/fimmu.2023.1240089. eCollection 2023.
2
Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin.病例报告:高剂量甲泼尼龙和静脉注射免疫球蛋白成功治疗一例抗D2R和DPPX抗体相关的自身免疫性脑炎患者
Front Immunol. 2024 Feb 26;15:1338714. doi: 10.3389/fimmu.2024.1338714. eCollection 2024.
3
Autoimmune GFAP astrocytopathy after viral encephalitis: a case report of bimodal overlapping encephalitis.自身免疫性 GFAP 星形胶质细胞病继发病毒性脑炎:双峰重叠性脑炎 1 例报告
Front Immunol. 2023 Sep 13;14:1258048. doi: 10.3389/fimmu.2023.1258048. eCollection 2023.
4
[High Dose Intravenous Immunoglobulin Therapy for Autoimmune Diseases of the Central Nervous System].[大剂量静脉注射免疫球蛋白治疗中枢神经系统自身免疫性疾病]
Brain Nerve. 2021 May;73(5):420-424. doi: 10.11477/mf.1416201781.
5
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].静脉注射免疫球蛋白治疗儿童自身免疫性神经疾病
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8):83-93. doi: 10.17116/jnevro20151156183-93.
6
High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.大剂量类固醇作为一线治疗会增加抗 NMDAR 脑炎患者院内感染的风险。
Front Immunol. 2021 Dec 17;12:774664. doi: 10.3389/fimmu.2021.774664. eCollection 2021.
7
Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: A case report.静脉注射免疫球蛋白治疗对类固醇敏感的自身免疫性胶质纤维酸性蛋白星形细胞病失败:一例报告。
Mult Scler Relat Disord. 2021 Jun;51:102933. doi: 10.1016/j.msard.2021.102933. Epub 2021 Apr 4.
8
Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.纳武利尤单抗-伊匹木单抗联合治疗引起的血清阴性脑炎;对类固醇加静脉注射免疫球蛋白(IVIG)治疗反应迅速。
J Oncol Pharm Pract. 2023 Apr;29(3):760-763. doi: 10.1177/10781552221118529. Epub 2022 Aug 8.
9
Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review.静脉注射免疫球蛋白治疗病毒性脑炎的疗效和安全性:系统文献回顾。
J Neurol. 2022 Feb;269(2):712-724. doi: 10.1007/s00415-021-10494-w. Epub 2021 Mar 6.
10
Intravenous immunoglobulin in autoimmune neuromuscular diseases.静脉注射免疫球蛋白在自身免疫性神经肌肉疾病中的应用
JAMA. 2004 May 19;291(19):2367-75. doi: 10.1001/jama.291.19.2367.

引用本文的文献

1
The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections.静脉注射免疫球蛋白疗法对与病毒性呼吸道感染相关的资源利用的影响。
Front Immunol. 2025 Aug 6;16:1513712. doi: 10.3389/fimmu.2025.1513712. eCollection 2025.
2
Experience of carbon monoxide poisoning treated with hyperbaric oxygen therapy and steroid pulse therapy: a case report.高压氧疗法和类固醇脉冲疗法治疗一氧化碳中毒的经验:一例报告。
Int J Emerg Med. 2025 Aug 18;18(1):153. doi: 10.1186/s12245-025-00966-5.
3
Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin.

本文引用的文献

1
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.基线血浆骨桥蛋白蛋白升高预示住院 COVID-19 患者不良结局。
Viruses. 2023 Feb 25;15(3):630. doi: 10.3390/v15030630.
2
AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines-A Systematic Review.人工智能冠状病毒研究:与新冠病毒及其疫苗相关的自身免疫性脑炎——一项系统综述
J Clin Neurol. 2022 Nov;18(6):692-710. doi: 10.3988/jcn.2022.18.6.692.
3
Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
病例报告:高剂量甲泼尼龙和静脉注射免疫球蛋白成功治疗一例抗D2R和DPPX抗体相关的自身免疫性脑炎患者
Front Immunol. 2024 Feb 26;15:1338714. doi: 10.3389/fimmu.2024.1338714. eCollection 2024.
新型冠状病毒与人类内分泌细胞之间的分子模拟:新冠后内分泌自身免疫的一个先决条件?
Pathophysiology. 2022 Aug 25;29(3):486-494. doi: 10.3390/pathophysiology29030039.
4
Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature.新型冠状病毒肺炎感染中的自身免疫性脑炎:我们的经验及文献系统综述
Biomedicines. 2022 Mar 25;10(4):774. doi: 10.3390/biomedicines10040774.
5
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein.住院 COVID-19 患者的预后标志物:IP-10 和 C 反应蛋白的作用。
Dis Markers. 2022 Feb 28;2022:3528312. doi: 10.1155/2022/3528312. eCollection 2022.
6
New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.新冠病毒感染后自身免疫性疾病的新发病例。
Cells. 2021 Dec 20;10(12):3592. doi: 10.3390/cells10123592.
7
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19.严重急性呼吸综合征冠状病毒 2 感染所致免疫介导性神经系统综合征:COVID-19 相关自身免疫性脑炎文献复习。
Neurol Sci. 2022 Mar;43(3):1533-1547. doi: 10.1007/s10072-021-05785-z. Epub 2021 Dec 1.
8
Autoimmune hepatitis triggered by COVID-19: A report of two cases.新型冠状病毒肺炎引发的自身免疫性肝炎:两例报告
Liver Int. 2021 Oct;41(10):2527-2528. doi: 10.1111/liv.15044. Epub 2021 Sep 3.
9
Autoimmune complications of COVID-19.新型冠状病毒肺炎的自身免疫并发症
J Med Virol. 2022 Jan;94(1):54-62. doi: 10.1002/jmv.27292. Epub 2021 Aug 31.
10
Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors.COVID-19 相关脑炎:发病率、结局和预测因素的系统评价和荟萃分析。
Eur J Neurol. 2021 Oct;28(10):3491-3502. doi: 10.1111/ene.14913. Epub 2021 Jun 2.